Garry John
Impact in
-
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Education
-
- Clinical Laboratory Practices and Quality Control
Papers in
-
- Diabetes Management and Research 9
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
- Diabetes Treatment and Management 1
- Surgery 2
- Pancreatic function and diabetes 2
- Co-authors
- Ragnar Hanås (7 shared papers)Emma English (3 shared papers)Philippe Gillery (1 shared paper)Cas Weykamp (1 shared paper)Randie R. Little (1 shared paper)Erna Lenters‐Westra (1 shared paper)Gojka Roglić (1 shared paper)David B. Sacks (1 shared paper)
- Journals
- Clinical Chemistry (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)Diabetes Care (1 paper)Annals of Clinical Biochemistry International Journal of Laboratory Medicine (1 paper)Diabetic Medicine (1 paper)
- Partner nations
- United KingdomSwedenUnited States
In The Last Decade
Garry John
10 papers receiving 319 citations
Peers
Comparison fields: 5 of 56
- Endocrinology, Diabetes and Metabolism 173
- Physiology 38
- Genetics 35
- Statistics, Probability and Uncertainty 9
- Clinical Biochemistry 8
Countries citing papers authored by Garry John
This map shows the geographic impact of Garry John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry John more than expected).
Fields of papers citing papers by Garry John
This network shows the impact of papers produced by Garry John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry John. The network helps show where Garry John may publish in the future.
Co-authors
The 11 scholars most cited alongside Garry John, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 164 | |
| 2 | 2015 | 59 | |
| 3 | 2010 | 41 | |
| 4 | 2010 | 23 | |
| 5 | 2010 | 17 | |
| 6 | 2012 | 11 | |
| 7 | 2009 | 9 | |
| 8 | 2014 | 8 | |
| 9 | 2010 | 8 | |
| 10 | 2010 | 3 |
About Garry John
Garry John is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine and Infectious Diseases, having authored 10 papers that have together received 343 indexed citations. Recurring topics across this work include Diabetes Management and Research (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers), Pancreatic function and diabetes (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Diabetes Treatment and Management (1 paper) and Cardiovascular Function and Risk Factors (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (173 citations), Physiology (38 citations), Genetics (35 citations), Statistics, Probability and Uncertainty (9 citations) and Clinical Biochemistry (8 citations). Garry John has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Ragnar Hanås, Emma English, Philippe Gillery, Cas Weykamp, Randie R. Little, Erna Lenters‐Westra, Gojka Roglić, David B. Sacks, Linong Ji and Izumi Takei. Their work appears in journals such as Clinical Chemistry, Clinical Chemistry and Laboratory Medicine (CCLM), Diabetes Care, Annals of Clinical Biochemistry International Journal of Laboratory Medicine and Diabetic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.